Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: monotherapy.

G, Skowron

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 1992

Data sources: Europe PubMed Central

Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: monotherapy.

descriptionPublicationkeyboard_double_arrow_right Article 18 Sep 1992 English Journal:Hospital practice (Office ed.), volume 27 Suppl 2 (issn: 8750-2836,

Copyright policy )

Authors: G, Skowron;

pmid: 1324257

Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: monotherapy.

- Summary
- Subjects
- Metrics

Abstract

At present, the nucleoside analogues are the cornerstone of therapy for HIV infection. Of the three that have been approved for clinical use, AZT is the only one that has clearly proved to prolong survival. ddI is indicated for patients who develop toxicity or resistance to AZT. Current data do not support ddC monotherapy as first-line treatment.

Related Organizations

Brown University
United States

Keywords

Acquired Immunodeficiency Syndrome, Didanosine, Time Factors, Zalcitabine, HIV-1, Humans, Drug Resistance, Microbial, HIV Infections, Antiviral Agents, Zidovudine

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	3
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average